Non-dystrophic myotonias
|
Pathologies in which myotonia is isolated and generally associated with muscle hypertrophy.
Different types have been identified:
- the congenital myotonias: (Thomsen disease if autosomal dominant transmission, Becker disease if autosomal recessive transmission) (see these terms): channelopathy due to a mutation of the CLCN1 gene (7q35)
- the congenital paramyotonia: channelopathy of the Nav1.4 sodium channel due to a 'gain of function' mutation of the SCN4A gene (17q23-25)
- the so-called potassium-aggravated myotonias channelopathies of the Nav1.4 sodium channel due to a 'gain of function' mutation of the SCN4A gene (17q23-25): myotonia fluctuans, myotonia permanens and acetazolamide-responsive myotonia
- the familial periodic hyperkalemic paralysis, also caused by a 'gain of function' mutation of the SCN4A gene (17q23-25), sometimes associated to myotonia
- the SNEL syndrome, often considered as a form of myotonia permanens
- the Schwartz Jampel syndrome
Anesthetic implications:
see the specific files
References :
- Farbu E, Softeland E, Dindoff LA.
Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders.
Acta Anaesthesiol Scand 2003; 47: 630-4.
- Stunnenberg BC, LoRusso S, Arnold WD, Barohn RJ, Cannon SC et al.
Guidelines on clinical presentation and management of nondystrophic myotonias.
Muscle Nerve 2020; 62:430-44.
Updated: January 2021